Gender-affirming care in US under threat from new Trump policies
President-elect Donald Trump campaigned in 2024 on a chaotic platform that included promises to roll back access to gender-affirming care…
All articles by GlobalData Healthcare
GlobalData Healthcare
-
-
Election outcomes and their implications for medical device pricing
Recent governmental elections could significantly influence the pricing landscape for medical devices, driven by anticipated changes in healthcare policies, trade…
-
Revolutionising breast cancer diagnosis: Seno Medical gains Vizient contract
Seno Medical has secured an innovative technology contract with Vizient Inc for its Imagio breast imaging system, a groundbreaking device…
-
Advances in AI-driven cardiac devices pave way for personalised heart care
Recent research highlights groundbreaking progress in the development of adaptive cardiac monitoring and therapeutic devices, showcasing the transformative potential of…
-
Advancements and market trends in arteriotomy closure devices
Arteriotomy closure devices are essential in managing access sites after procedures such as angiography or vascular interventions. The rise in…
-
US electrophysiology diagnostic catheter market to grow at 10% CAGR to 2033
The US electrophysiology (EP) diagnostic catheter market is expected to see consistent growth, particularly the segment for advanced EP diagnostic…
-
FDA approves Omron AI-powered AFib detection in blood pressure monitors
In October 2024, Omron Healthcare received de novo authorisation from the US Food and Drugs Administration (FDA) to market its…
-
Emerging blood-based tests: a new frontier in Alzheimer’s diagnosis
Blood-based diagnostic tests are gaining traction as a potential method for the early detection of Alzheimer’s disease, providing an accessible…
-
Experts at AdvaMed’s MedTech conference probe future of IVD
Innovation is afoot in the field of in vitro diagnostics (IVD), driving a transformative shift in healthcare and propelled by advances…
-
Diagnostic industry concerned by FDA’s final rule on LDTs
The FDA's recent final rule on laboratory-developed tests (LDTs) marks a significant shift in the regulation of diagnostic tests. Historically,…